Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
6,765 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00002811 | T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum | unknown | Phase 3 | 30 | Applied GeneticsINDUSTRY | 3 | Nov 6, 2013 | clinicaltrials |
| NCT00003012 | Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer | completed | Phase 3 | 1,000 | Scottish Cancer Therapy NetworkOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00003679 | Combination Chemotherapy in Treating Women With Breast Cancer | unknown | Phase 3 | 350 | Scottish Cancer Therapy NetworkOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00003680 | Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer | unknown | Phase 3 | 300 | Scottish Cancer Therapy NetworkOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00003991 | Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia | completed | Phase 3 | 360 | Maxim PharmaceuticalsINDUSTRY | 12 | Nov 6, 2013 | clinicaltrials |
| NCT00004237 | Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer | completed | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00004256 | Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer | completed | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00005058 | Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast Cancer | unknown | N/A | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00005071 | Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer | unknown | N/A | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00005600 | Axillary Drainage Following Lymph Node Dissection in Women With Stage I or Stage II Breast Cancer | unknown | N/A | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00005821 | Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer | unknown | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00006045 | Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia | unknown | Phase 3 | — | Facet BiotechINDUSTRY | 7 | Nov 6, 2013 | clinicaltrials |
| NCT00022204 | Vitamin E and Pentoxifylline in Treating Women With Lymphedema After Radiation Therapy for Breast Cancer | completed | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00036998 | Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer | unknown | Phase 2 | — | ImunonINDUSTRY | 2 | Nov 6, 2013 | clinicaltrials |
| NCT00041223 | IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer | unknown | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00112554 | Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia | completed | Phase 3 | 420 | Vion PharmaceuticalsINDUSTRY | 10 | Nov 6, 2013 | clinicaltrials |
| NCT00320190 | Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib | terminated | Phase 2 | 52 | Bristol-Myers SquibbINDUSTRY | 11 | Oct 30, 2013 | clinicaltrials |
| NCT01653158 | CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies | completed | Phase 1 | 46 | PfizerINDUSTRY | 1 | Oct 30, 2013 | clinicaltrials |
| NCT00014612 | Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast Cancer(AMAROS) | completed | Phase 3 | 4,813 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Oct 29, 2013 | clinicaltrials |
| NCT00454376 | Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors | unknown | — | 408 | National Cancer Institute (NCI)NIH | 10 | Oct 29, 2013 | clinicaltrials |
| NCT00457392 | A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone | completed | Phase 3 | 960 | PfizerINDUSTRY | 26 | Oct 29, 2013 | clinicaltrials |
| NCT00564694 | Studying a Quality of Life Questionnaire in Patients With Colorectal Cancer | completed | — | 350 | National Cancer Institute (NCI)NIH | 3 | Oct 29, 2013 | clinicaltrials |
| NCT00017095 | Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer | completed | Phase 3 | 1,856 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Oct 24, 2013 | clinicaltrials |
| NCT00066378 | Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer | completed | Phase 2 | 71 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Oct 24, 2013 | clinicaltrials |
| NCT00382031 | Zalutumumab in Patients With Non-curable Head and Neck Cancer | completed | Phase 3 | 286 | GenmabINDUSTRY | 12 | Oct 15, 2013 | clinicaltrials |
| NCT00044551 | Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma | completed | Phase 2 | 29 | BayerINDUSTRY | 6 | Oct 14, 2013 | clinicaltrials |
| NCT00333840 | Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia | completed | Phase 3 | 1,106 | Novartis PharmaceuticalsINDUSTRY | 16 | Oct 14, 2013 | clinicaltrials |
| NCT01233492 | Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme | terminated | Phase 1 | 36 | Cancer Research UKOTHER | 1 | Oct 8, 2013 | clinicaltrials |
| NCT01905462 | Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix Residing in UK | completed | — | 1,046 | GlaxoSmithKlineINDUSTRY | 1 | Sep 30, 2013 | clinicaltrials |
| NCT01147939 | Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)(CLAVELA) | completed | Phase 3 | 381 | Clavis PharmaINDUSTRY | 13 | Sep 27, 2013 | clinicaltrials |
| NCT01086254 | SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer | completed | Phase 2 | 119 | SanofiINDUSTRY | 5 | Sep 24, 2013 | clinicaltrials |
| NCT01258816 | The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055) | completed | Phase 1 | 43 | Clavis PharmaINDUSTRY | 2 | Sep 23, 2013 | clinicaltrials |
| NCT01948362 | Sulforadex in Healthy Volunteers SAD | completed | Phase 1 | 29 | Evgen PharmaINDUSTRY | 1 | Sep 23, 2013 | clinicaltrials |
| NCT00003578 | High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma | unknown | Phase 3 | 500 | Lymphoma Trials OfficeOTHER | 4 | Sep 20, 2013 | clinicaltrials |
| NCT00003602 | Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia | unknown | Phase 3 | 400 | Riverside Haematology GroupOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00003603 | Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma | unknown | Phase 3 | 660 | Riverside Haematology GroupOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00003617 | Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach | unknown | Phase 3 | 200 | Lymphoma Trials OfficeOTHER | 5 | Sep 20, 2013 | clinicaltrials |
| NCT00003733 | Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer | unknown | Phase 2 | 40 | SmithKline BeechamINDUSTRY | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00003747 | Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma | unknown | Phase 1 | 30 | Mount Vernon Cancer Centre at Mount Vernon HospitalOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00004887 | Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery | unknown | Phase 3 | — | The Christie NHS Foundation TrustOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00005038 | Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | — | The Christie NHS Foundation TrustOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00005054 | Temozolomide in Treating Women With Advanced Breast Cancer | unknown | Phase 2 | — | The Christie NHS Foundation TrustOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00006250 | Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma | unknown | Phase 3 | 500 | Lymphoma Trials OfficeOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00007826 | Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | — | OnyvaxINDUSTRY | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00022009 | Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | — | The Christie NHS Foundation TrustOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00022178 | Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin | unknown | Phase 3 | — | The Christie NHS Foundation TrustOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00031902 | Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma | unknown | Phase 1 | — | Lymphoma Trials OfficeOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00032149 | Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma | unknown | Phase 1 / Phase 2 | 30 | Lymphoma Trials OfficeOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00033436 | Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer | completed | Phase 3 | 330 | Mount Vernon Cancer Centre at Mount Vernon HospitalOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00041210 | Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma | unknown | Phase 3 | 850 | Mount Vernon Cancer Centre at Mount Vernon HospitalOTHER | 1 | Sep 20, 2013 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials